Profile | GDS5420 / 212445_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 200.34 | 52 |
GSM1296119 | B_lesional_pre-dose | 366.41 | 62 |
GSM1296076 | C_lesional_pre-dose | 312.8 | 61 |
GSM1296092 | D_lesional_pre-dose | 251.23 | 58 |
GSM1296103 | E_lesional_pre-dose | 239.98 | 56 |
GSM1296078 | F_lesional_pre-dose | 224.85 | 56 |
GSM1296107 | G_lesional_pre-dose | 252.32 | 56 |
GSM1296109 | H_lesional_pre-dose | 164.28 | 48 |
GSM1296080 | I_lesional_pre-dose | 343.07 | 62 |
GSM1296090 | J_lesional_pre-dose | 311.96 | 61 |
GSM1296074 | K_lesional_pre-dose | 258.86 | 59 |
GSM1296111 | L_lesional_pre-dose | 197.88 | 51 |
GSM1296099 | M_lesional_pre-dose | 307.14 | 59 |
GSM1296086 | O_lesional_pre-dose | 319.68 | 61 |
GSM1296117 | P_lesional_pre-dose | 151.05 | 46 |
GSM1296113 | Q_lesional_pre-dose | 154.66 | 46 |
GSM1296096 | R_lesional_pre-dose | 310.86 | 60 |
GSM1296105 | S_lesional_pre-dose | 427.28 | 65 |
GSM1296098 | T_lesional_pre-dose | 122.67 | 44 |
GSM1296101 | U_lesional_pre-dose | 142.43 | 46 |
GSM1296121 | V_lesional_pre-dose | 231.68 | 54 |
GSM1296088 | W_lesional_pre-dose | 356.21 | 62 |
GSM1296082 | X_lesional_pre-dose | 232.58 | 56 |
GSM1296115 | Y_lesional_pre-dose | 179.89 | 50 |
GSM1296084 | Z_lesional_pre-dose | 309.52 | 60 |
GSM1296072 | B_lesional_day8 | 352.36 | 61 |
GSM1296069 | L_lesional_day8 | 245.36 | 54 |
GSM1296071 | P_lesional_day8 | 262.36 | 55 |
GSM1296070 | Y_lesional_day8 | 263.79 | 56 |
GSM1296073 | V_lesional_day8 | 154.34 | 48 |
GSM1296034 | A_lesional_day15 | 289.26 | 57 |
GSM1296041 | G_lesional_day15 | 158.03 | 48 |
GSM1296035 | R_lesional_day15 | 311.2 | 59 |
GSM1296038 | U_lesional_day15 | 280.38 | 58 |
GSM1296047 | B_lesional_day15 | 397.82 | 63 |
GSM1296039 | E_lesional_day15 | 245.24 | 56 |
GSM1296042 | H_lesional_day15 | 179.16 | 49 |
GSM1296043 | L_lesional_day15 | 286.7 | 57 |
GSM1296037 | M_lesional_day15 | 579.36 | 70 |
GSM1296046 | P_lesional_day15 | 263.82 | 56 |
GSM1296044 | Q_lesional_day15 | 188.75 | 49 |
GSM1296045 | Y_lesional_day15 | 333.5 | 60 |
GSM1296025 | C_lesional_day15 | 416.87 | 65 |
GSM1296033 | D_lesional_day15 | 424.48 | 65 |
GSM1296027 | I_lesional_day15 | 595.12 | 71 |
GSM1296032 | J_lesional_day15 | 745.09 | 74 |
GSM1296024 | K_lesional_day15 | 293.65 | 59 |
GSM1296031 | W_lesional_day15 | 286.56 | 57 |
GSM1296028 | X_lesional_day15 | 476.21 | 67 |
GSM1296029 | Z_lesional_day15 | 388.6 | 63 |
GSM1296026 | F_lesional_day15 | 195.03 | 53 |
GSM1296030 | O_lesional_day15 | 345.07 | 62 |
GSM1296040 | S_lesional_day15 | 219.12 | 54 |
GSM1296036 | T_lesional_day15 | 164.88 | 48 |
GSM1296048 | V_lesional_day15 | 178.63 | 50 |
GSM1296059 | A_lesional_day43 | 263.19 | 57 |
GSM1296066 | G_lesional_day43 | 182.59 | 50 |
GSM1296060 | R_lesional_day43 | 368.74 | 62 |
GSM1296063 | U_lesional_day43 | 309.48 | 60 |
GSM1296064 | E_lesional_day43 | 363.74 | 63 |
GSM1296067 | H_lesional_day43 | 240.21 | 54 |
GSM1296062 | M_lesional_day43 | 358.61 | 61 |
GSM1296068 | Q_lesional_day43 | 252.12 | 54 |
GSM1296050 | C_lesional_day43 | 659.47 | 73 |
GSM1296057 | D_lesional_day43 | 601.32 | 70 |
GSM1296052 | I_lesional_day43 | 511.24 | 68 |
GSM1296054 | J_lesional_day43 | 404.26 | 63 |
GSM1296049 | K_lesional_day43 | 297.28 | 59 |
GSM1296055 | W_lesional_day43 | 383.12 | 63 |
GSM1296053 | X_lesional_day43 | 394.86 | 63 |
GSM1296058 | Z_lesional_day43 | 444.66 | 66 |
GSM1296051 | F_lesional_day43 | 342.18 | 62 |
GSM1296056 | O_lesional_day43 | 307.58 | 60 |
GSM1296065 | S_lesional_day43 | 470.27 | 66 |
GSM1296061 | T_lesional_day43 | 150.29 | 47 |
GSM1296095 | A_non-lesional_pre-dose | 336.73 | 61 |
GSM1296120 | B_non-lesional_pre-dose | 498.14 | 68 |
GSM1296077 | C_non-lesional_pre-dose | 414.86 | 65 |
GSM1296093 | D_non-lesional_pre-dose | 604.15 | 70 |
GSM1296104 | E_non-lesional_pre-dose | 607.59 | 71 |
GSM1296079 | F_non-lesional_pre-dose | 477.98 | 67 |
GSM1296108 | G_non-lesional_pre-dose | 251.97 | 55 |
GSM1296110 | H_non-lesional_pre-dose | 262.15 | 55 |
GSM1296081 | I_non-lesional_pre-dose | 725.29 | 74 |
GSM1296091 | J_non-lesional_pre-dose | 674.26 | 73 |
GSM1296075 | K_non-lesional_pre-dose | 288.86 | 60 |
GSM1296112 | L_non-lesional_pre-dose | 329.8 | 59 |
GSM1296100 | M_non-lesional_pre-dose | 991.42 | 79 |
GSM1296087 | O_non-lesional_pre-dose | 661.72 | 72 |
GSM1296118 | P_non-lesional_pre-dose | 650.37 | 72 |
GSM1296114 | Q_non-lesional_pre-dose | 255.04 | 55 |
GSM1296097 | R_non-lesional_pre-dose | 444.66 | 66 |
GSM1296106 | S_non-lesional_pre-dose | 395.41 | 63 |
GSM1296102 | U_non-lesional_pre-dose | 280.85 | 57 |
GSM1296122 | V_non-lesional_pre-dose | 338.91 | 61 |
GSM1296089 | W_non-lesional_pre-dose | 311.58 | 59 |
GSM1296083 | X_non-lesional_pre-dose | 441.93 | 65 |
GSM1296116 | Y_non-lesional_pre-dose | 438.88 | 65 |
GSM1296085 | Z_non-lesional_pre-dose | 904.06 | 77 |